About This Page
This is a clinician-written, evidence-based summary aligned to the USMLE Step 2 CK Content Outline. It is intended for medical students preparing for USMLE Step 2 CK. Management reflects current ACC/AHA, USPSTF, and APA guidelines. Always cross-reference with UpToDate, institutional protocols, and clinical judgment.
The Bottom Line
- USPSTF: ask all adults about tobacco use, advise cessation, and provide behavioral interventions plus FDA-approved pharmacotherapy for nonpregnant adults
- The 5 As: Ask, Advise, Assess, Assist, Arrange
- First-line pharmacotherapy: varenicline, combination NRT, or bupropion SR; varenicline is often the most effective single agent
- Pregnancy: behavioral interventions first; evidence is insufficient for routine pharmacotherapy in pregnant patients
- Do not use e-cigarettes as a recommended first-line cessation therapy in exam settings; evidence and regulation remain less certain
Overview
Tobacco use is the leading preventable cause of disease and death in the United States. Smoking causes lung cancer, COPD, cardiovascular disease, stroke, peripheral arterial disease, pregnancy complications, poor wound healing, and many other cancers. Tobacco cessation is high-yield because brief clinician advice, structured counseling, quitlines, and pharmacotherapy all improve quit rates. Step 2 CK questions often test the most effective next step: do not simply document smoking status; offer direct help unless the patient declines.
Epidemiology
Cigarette smoking prevalence has declined substantially in the United States but remains concentrated among people with lower income, lower educational attainment, mental health disorders, substance use disorders, housing insecurity, and limited healthcare access. Most smokers want to quit and make multiple quit attempts before long-term abstinence. Combining behavioral support with pharmacotherapy is more effective than either alone in nonpregnant adults.
Assessment Features
Symptoms
Current cigarette, cigar, pipe, smokeless tobacco, or nicotine vaping use should be documented at every visit
Nicotine dependence: smoking soon after waking, withdrawal symptoms, high daily cigarette count, and failed quit attempts
Motivated smoker ready to quit: set a quit date and offer pharmacotherapy plus counseling
Unmotivated smoker: use motivational interviewing and the 5 Rs (Relevance, Risks, Rewards, Roadblocks, Repetition)
Pregnant smoker: provide pregnancy-tailored behavioral counseling and avoid reflex pharmacotherapy as first answer
Hemoptysis, weight loss, or persistent cough in a smoker requires diagnostic evaluation, not cessation counseling alone
Signs
Tobacco odor, nicotine staining, wheeze, chronic cough, or signs of COPD may be present but many patients are asymptomatic
Comorbid depression, alcohol use disorder, or opioid use disorder increases relapse risk and should be addressed
Contraindication to bupropion: seizure disorder, bulimia/anorexia nervosa, or abrupt withdrawal from alcohol/benzodiazepines
Recent cardiovascular disease does not automatically preclude NRT, but clinical judgment is required
Assessment and Monitoring
First-line
Tobacco-use historyCurrent use, type, cigarettes/day, pack-years, time to first cigarette, prior quit attempts, triggers, household exposure, and readiness to quit
Readiness assessmentAsk whether the patient is willing to make a quit attempt in the next 30 days. Tailor approach to readiness without abandoning advice
Medication and psychiatric historyScreen for seizure risk before bupropion, psychiatric comorbidity, pregnancy, and drug interactions
Second-line
Lung cancer screening eligibilityAge 50-80, >=20 pack-years, current smoking or quit within 15 years: annual LDCT, separate from cessation intervention
COPD assessmentSpirometry if chronic dyspnea, cough, sputum, or wheeze; do not screen asymptomatic adults with spirometry
Carbon monoxide or cotinine testingMay be used in structured programs but is not required for routine primary care cessation
Specialist
Quitline or tobacco treatment specialist referral1-800-QUIT-NOW, text/app programs, group counseling, or intensive tobacco treatment for high dependence or repeated relapse
Behavioral health integrationUseful when tobacco use coexists with depression, anxiety, alcohol use disorder, PTSD, or serious mental illness
Cessation Management
USPSTF Tobacco Smoking Cessation in Adults Recommendation 2021; US Public Health Service Tobacco Dependence Guideline principles1
5 As framework
- Ask about tobacco use at every visit
- Advise all tobacco users to quit with clear, personalized, nonjudgmental advice
- Assess willingness to make a quit attempt
- Assist with quit plan, medication, counseling, triggers, and problem-solving
- Arrange follow-up soon after quit date and repeatedly thereafter
2
First-line pharmacotherapy for nonpregnant adults
- Varenicline: partial nicotinic receptor agonist; start 1 week before quit date; nausea and vivid dreams are common
- Combination NRT: long-acting patch plus short-acting gum/lozenge/inhaler/nasal spray for breakthrough cravings
- Bupropion SR: start 1-2 weeks before quit date; useful with depression or concern about weight gain; avoid in seizure/eating disorders
- Combination of behavioral counseling plus pharmacotherapy is preferred when possible
3
Pregnancy and adolescents
- Pregnancy: ask, advise, and provide behavioral interventions; pharmacotherapy evidence is insufficient and should not be the routine first answer
- Adolescents: prevention and counseling are important; pharmacotherapy evidence is less robust than in adults
- Avoid secondhand smoke exposure and counsel household members when appropriate
4
Relapse prevention
- Normalize relapse as common and restart treatment promptly
- Identify triggers: stress, alcohol, social cues, morning routine, driving, meals, and psychiatric symptoms
- Follow up within 1-2 weeks of quit date and again over subsequent months
- Treat comorbid alcohol use, depression, anxiety, and chronic pain to improve quit success
Complications
- Withdrawal: Irritability, anxiety, insomnia, increased appetite, poor concentration, depressed mood, and cravings
- Relapse: Common after stress, alcohol use, or inadequate medication duration
- Medication adverse effects: Varenicline causes nausea/vivid dreams; bupropion lowers seizure threshold; NRT can cause skin irritation or dyspepsia
- Ongoing smoking: Lung cancer, COPD, MI, stroke, PAD, infertility, pregnancy complications, and postoperative complications
- Health inequity: Cessation success is lower when counseling, medications, and follow-up are financially or geographically inaccessible
USMLE Step 2 CK Exam Tips
- 1Smoker ready to quit = behavioral counseling plus pharmacotherapy, not advice alone
- 2Varenicline or combination NRT are excellent first-line answers for nonpregnant adults
- 3Pregnant smoker = behavioral intervention first; do not jump to varenicline or bupropion
- 4Bupropion is contraindicated in seizure disorder and eating disorders
- 5The 5 As are Ask, Advise, Assess, Assist, Arrange
- 6Unmotivated patient = motivational interviewing / 5 Rs, not dismissal or no intervention
- 7Smoking history also triggers lung cancer screening eligibility: 50-80, >=20 pack-years, current or quit <15 years
- 8E-cigarettes are not the preferred board-style cessation treatment over approved pharmacotherapies
practicetest your knowledge on tobacco cessationApply what you've learnt with USMLE Step 2 CK-style questions from the iatroX Q-Bank — preventive medicine and beyond.
open q-bank